New study: medical procedure removes up to 50% of microplastics from human blood

Scientists have discovered a medical procedure capable of removing microplastics from human blood. In trials, microplastic levels in patients' blood were reduced by approximately 50%, which researchers say could mark a significant step toward reducing the health impacts of microplastic exposure.

Scientists have made a breakthrough discovery, finding that a medical procedure can effectively remove accumulated microplastics from human blood. In clinical trials, the microplastic content in patients' blood dropped by roughly 50%, a result that researchers describe as highly promising.

The findings suggest that targeted medical intervention could play a meaningful role in addressing the growing concern over microplastic contamination in the human body. Microplastics — tiny plastic particles — have been detected in blood, lungs, and even brain tissue in recent years, raising alarm among health researchers worldwide.

While the study does not yet identify the precise health consequences of microplastic accumulation, scientists believe that reducing their presence in the bloodstream could lower associated health risks. Researchers noted that a 50% reduction in a single procedure is a significant result that warrants further investigation and potential development into broader clinical use.

The discovery adds momentum to a rapidly expanding field of research focused on understanding and countering the effects of plastic pollution on human health. As microplastic contamination becomes increasingly widespread in food, water, and air, the need for medical countermeasures has grown more urgent.